Poor Outcome of RUNX1-Mutated (RUNX1-mut) Patients (Pts) with Primary, Cytogenetically Normal Acute Myeloid Leukemia (CN-AML) and Associated Gene- and MicroRNA (miR) Expression Signatures

被引：0
|
作者：
Mendler, Jason H. [1 ]
Maharry, Kati [1 ]
Radmacher, Michael D. [1 ]
Mrozek, Krzysztof [1 ]
Kohlschmidt, Jessica [1 ]
Nicolet, Deedra [1 ]
Becker, Heiko [1 ]
Metzeler, Klaus H. [1 ]
Schwind, Sebastian [1 ]
Whitman, Susan P. [1 ]
Blum, William [1 ]
Powell, Bayard L. [2 ]
Kolitz, Jonathan E. [3 ]
Carter, Thomas H. [4 ]
Wetzler, Meir [5 ]
Moore, Joseph O. [6 ]
Carroll, Andrew J. [7 ]
Baer, Maria R. [8 ]
Larson, Richard A. [9 ]
Caligiuri, Michael A. [1 ]
Marcucci, Guido [10 ]
Bloomfield, Clara D. [1 ]
机构：
[1] Ohio State Univ, Ctr Comprehens Canc, Columbus, OH 43210 USA
[2] Wake Forest Univ, Ctr Comprehens Canc, Winston Salem, NC 27109 USA
[3] N Shore Long Isl Jewish Hlth Syst, Dept Med, Lake Success, NY USA
[4] Univ Iowa, Iowa City, IA USA
[5] Roswell Pk Canc Inst, Buffalo, NY 14263 USA
[6] Duke Univ, Med Ctr, Durham, NC USA
[7] Univ Alabama, Dept Genet, Birmingham, AL USA
[8] Univ Maryland, Greenebaum Canc Ctr, Baltimore, MD 21201 USA
[9] Univ Chicago, Chicago, IL 60637 USA
[10] Ohio State Univ, Div Hematol, Columbus, OH 43210 USA
来源：
BLOOD | 2011年 / 118卷 / 21期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：1476 / 1477
页数：2
相关论文
共 43 条
  • [31] IDH1 AND IDH2 GENE MUTATIONS IDENTIFY NOVEL MOLECULAR SUBSETS WITHIN DE NOVO CYTOGENETICALLY NORMAL ACUTE MYELOID LEUKEMIA (CN-AML): A CANCER AND LEUKEMIA GROUP B (CALGB) STUDY
    Marcucci, G.
    Maharry, K.
    Wu, Y. Z.
    Radmacher, M.
    Mrozek, K.
    Margeson, D.
    Holland, K.
    Whitman, S.
    Becker, H.
    Schwind, S.
    Metzeler, K.
    Powell, B.
    Carter, T.
    Kolitz, J.
    Wetzler, M.
    Baer, M.
    Carroll, A.
    Caligiuri, M.
    Larson, R.
    Bloomfield, C.
    HAEMATOLOGICA-THE HEMATOLOGY JOURNAL, 2010, 95 : 456 - 456
  • [32] BAALC and ERG expression levels are associated with outcome and distinct gene and microRNA expression profiles in older patients with de novo cytogenetically normal acute myeloid leukemia: a Cancer and Leukemia Group B study
    Schwind, Sebastian
    Marcucci, Guido
    Maharry, Kati
    Radmacher, Michael D.
    Mrozek, Krzysztof
    Holland, Kelsi B.
    Margeson, Dean
    Becker, Heiko
    Whitman, Susan P.
    Wu, Yue-Zhong
    Metzeler, Klaus H.
    Powell, Bayard L.
    Kolitz, Jonathan E.
    Carter, Thomas H.
    Moore, Joseph O.
    Baer, Maria R.
    Carroll, Andrew J.
    Caligiuri, Michael A.
    Larson, Richard A.
    Bloomfield, Clara D.
    BLOOD, 2010, 116 (25) : 5660 - 5669
  • [33] ACUTE MYELOID LEUKEMIA WITH RUNX1 MUTATIONS CONSTITUTE A DISTINCT ENTITY ASSOCIATED WITH CHARACTERISTIC CLINICAL AND GENETIC FEATURES AND POOR OUTCOME. A STUDY OF THE AML STUDY GROUP (AMLSG)
    Gaidzik, V. I.
    Teleanu, V.
    Schlenk, R. F.
    Spaeth, D.
    Paschka, P.
    Hahn, J.
    Koehne, C. H.
    Horst, H. A.
    Schmidt-Wolf, I.
    Held, G.
    Kuendgen, A.
    Ringhoffer, M.
    Goetze, K.
    Rummel, M.
    Wulf, G.
    Nachbaur, D.
    Fiedler, W.
    Corbacioglu, A.
    Bullinger, L.
    Schlegelberger, B.
    Thol, F.
    Heuser, M.
    Ganser, A.
    Doehner, K.
    Doehner, H.
    HAEMATOLOGICA, 2014, 99 : 257 - 257
  • [34] microRNA (miR)-9 directly downregulates the oncogenic transcription factor ets related gene (ERG) & high expression associates with improved outcome in patients (pts) with acute myeloid leukemia (AML)
    Grimm, J.
    Bill, M.
    Weidner, H.
    Knyrim, M.
    Schmalbrock, L.
    Jentzsch, M.
    Schubert, K.
    Wurm, A.
    Gerloff, D.
    Cross, M.
    Lange, T.
    Behre, G.
    Niederwieser, D.
    Schwind, S.
    Oncology Research and Treatment, 2015, 38 : 162 - 162
  • [35] Prognostic impact of NPM1 mutations in cytogenetically normal (CN) acute myeloid leukemia (AML) is adversely affected by high expression of the ERG gene:: A cancer and leukemia group B (CALGB) study
    Paschka, P.
    Marcucci, G.
    Maharry, K.
    Whitman, S. P.
    Ruppert, A. S.
    Vukosavljevic, T.
    Mrozek, K.
    Powell, B. L.
    Kolitz, J. E.
    Larson, R. A.
    Bloomfield, C. D.
    HAEMATOLOGICA-THE HEMATOLOGY JOURNAL, 2007, 92 : 145 - 145
  • [36] CEBPA DOUBLE MUTATIONS IMPACT FAVORABLY ON THE OUTCOME OF OLDER ADULTS WITH WILD-TYPE NPM1 CYTOGENETICALLY NORMAL ACUTE MYELOID LEUKEMIA AND ARE ASSOCIATED WITH DISTINCT GENE AND MICRORNA EXPRESSION
    Becker, H.
    Marcucci, G.
    Maharry, K.
    Radmacher, M.
    Wu, Y.
    Mrozek, K.
    Whitman, S.
    Margeson, D.
    Holland, K.
    Schwind, S.
    Metzeler, K.
    Powell, B.
    Carter, T.
    Kolitz, J.
    Wetzler, M.
    Carroll, A.
    Baer, M.
    Moore, J.
    Caligiuri, M.
    Larson, R.
    Bloomfield, C.
    HAEMATOLOGICA-THE HEMATOLOGY JOURNAL, 2010, 95 : 247 - 248
  • [37] Clinical outcome and gene- and microRNA-expression profiling according to the Wilms tumor 1 (WT1) single nucleotide polymorphism rs16754 in adult de novo cytogenetically normal acute myeloid leukemia: a Cancer and Leukemia Group B study
    Becker, Heiko
    Maharry, Kati
    Radmacher, Michael D.
    Mrozek, Krzysztof
    Metzeler, Klaus H.
    Whitman, Susan P.
    Schwind, Sebastian
    Kohlschmidt, Jessica
    Wu, Yue-Zhong
    Powell, Bayard L.
    Carter, Thomas H.
    Kolitz, Jonathan E.
    Wetzler, Meir
    Carroll, Andrew J.
    Baer, Maria R.
    Moore, Joseph O.
    Caligiuri, Michael A.
    Larson, Richard A.
    Marcucci, Guido
    Bloomfield, Clara D.
    HAEMATOLOGICA-THE HEMATOLOGY JOURNAL, 2011, 96 (10): : 1488 - 1495
  • [38] FLT3 internal tandem duplication associates with adverse outcome and gene-and microRNA-expression signatures in patients 60 years of age or older with primary cytogenetically normal acute myeloid leukemia: a Cancer and Leukemia Group B study
    Whitman, Susan P.
    Maharry, Kati
    Radmacher, Michael D.
    Becker, Heiko
    Mrozek, Krzysztof
    Margeson, Dean
    Holland, Kelsi B.
    Wu, Yue-Zhong
    Schwind, Sebastian
    Metzeler, Klaus H.
    Wen, Jing
    Baer, Maria R.
    Powell, Bayard L.
    Carter, Thomas H.
    Kolitz, Jonathan E.
    Wetzler, Meir
    Moore, Joseph O.
    Stone, Richard M.
    Carroll, Andrew J.
    Larson, Richard A.
    Caligiuri, Michael A.
    Marcucci, Guido
    Bloomfield, Clara D.
    BLOOD, 2010, 116 (18) : 3622 - 3626
  • [39] Mutation of the DNMT3A and IDH1/2 genes in Iranian acute myeloid leukemia patients with normal karyotype (CN-AML): association with other gene mutation and clinical and laboratory characteristics
    Mahdiyar Iravani Saadi
    Tahereh Zarei
    Mani Ramzi
    Nargess Arandi
    Journal of Hematopathology, 2018, 11 : 29 - 36
  • [40] Mutation of the DNMT3A and IDH1/2 genes in Iranian acute myeloid leukemia patients with normal karyotype (CN-AML): association with other gene mutation and clinical and laboratory characteristics
    Saadi, Mandiyar Iravani
    Zarei, Tahereh
    Ramzi, Mani
    Arandi, Nargess
    JOURNAL OF HEMATOPATHOLOGY, 2018, 11 (02) : 29 - 36
12345